Pursuant to Regulation 30 read with Sub para 15, Para A Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has informed BSE that the audio recording of its Q3 & 9 Months FY26 Earnings Conference Call, held on 12th February 2026, is now available on the company's website under the investor relations section. The call discussed the un-audited financial results for the quarter ended 31st December 2025. This is a standard regulatory filing under SEBI Listing Obligations (Regulation 30) to disclose the availability of the earnings call recording for shareholders and the public. No new financial figures, guidance, or strategic announcements are included in this filing itself.
No direct impact on shareholders or stock price — this is a routine compliance disclosure. Investors interested in management commentary on Q3 performance can listen to the recorded call via the provided link.